Clinical Trial Update: A Study of YL202 in Selected Patients With Advanced Solid Tumors [Phase 2]

View source ↗

Summary

Phase 2 study of YL202 in selected patients with advanced solid tumors including non-small cell lung cancer, breast cancer, and head and neck squamous cell carc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Head and Neck Squamous Cell Carcinoma
• Non-small Cell Lung Cancer

Drugs mentioned

• YL202

Snippet

Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd. | Conditions: NSCLC, Breast Cancer | Phase 2 | Status: RECRUITING